SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-003963
Filing Date
2021-08-27
Accepted
2021-08-27 16:01:40
Documents
12
Period of Report
2021-08-23
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K coeptis_8k.htm   iXBRL 8-K 25092
  Complete submission text file 0001683168-21-003963.txt   193216

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE coep-20210823.xsd EX-101.SCH 3027
3 XBRL LABEL FILE coep-20210823_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE coep-20210823_pre.xml EX-101.PRE 22360
5 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_8k_htm.xml XML 3390
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Inc. (Filer) CIK: 0001819663 (see all company filings)

IRS No.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56194 | Film No.: 211218852
SIC: 2834 Pharmaceutical Preparations